Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 597 clinical trials
Impact of FDG-PET/CT on Management of Patients With Native Valve Infective Endocarditis

The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well …

  • 11 Apr, 2021
  • 3 locations
4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer respond to chemoradiation therapy.

  • 23 Mar, 2022
  • 1 location
Total-body 13N-NH3 PET/CT to Study the Blood Perfusion in Whole Body

The aim of our study is to analyze and quantitate whole-body blood perfusion by total-body 13N-NH3 PET/CT(uEXPLORER), and evaluate the influence to other organs caused by the decreased EF value

Accepts healthy volunteers
  • 08 Oct, 2021
  • 1 location
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.

The aim of this study is to detect bone metastases by PET/CT examination in cancer patients.

  • 08 May, 2021
  • 1 location
The Application Value of 18F Prostate-specific Membrane Antigen PET/CT in Prostate Cancer

, 18F-PSMA positron emission tomography/computerized tomography (PSMA PET/CT) has earned widespread attention as a novel imaging modality based on molecular-level analysis, rather than morphological or

Accepts healthy volunteers
  • 26 Apr, 2022
  • 1 location
Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT Measurements (ISGU)

In the absence of excessive alcohol consumption, increased levels of fat in the liver (>5%) are diagnosed as non-alcoholic fatty liver (NAFL). It has been shown that NAFL is strongly associated with impairments in metabolic health such as hepatic and whole-body insulin resistance. Insulin resistance is seen as the earliest …

Accepts healthy volunteers
  • 05 May, 2022
  • 1 location
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT (FTT 2)

to the imaging visit. The PET/CT scan will include an injection of [18F]FTT. Data will be collected to evaluate uptake of [18F]FTT in breast cancer and compare with PARP-1 activity in tissue, when

stage iv breast cancer
  • 12 May, 2022
  • 1 location
68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study

To evaluate the value of 68Ga-Pentixafor PET/CT in the diagnosis of primary aldosteronism subtype

  • 10 May, 2022
  • 1 location
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

The purpose of this study is to look at how safe 89Zr-DFO-SC16.56 is, and how it is processed by the body in people with small cell lung cancer.

platelet count
neuroendocrine tumor
liver metastasis
delta-like protein 3
  • 24 May, 2022
  • 1 location
A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer

detect primary lesions, recurrent and metastatic lesions of prostate cancer. In this prospective study, the investigators will use the most advanced imaging equipments, integrated PET/MR, and PET/CT with

pet/ct scan
gallium ga 68-labeled psma-11
bone scan
transrectal ultrasound
  • 09 May, 2022
  • 1 location